The global disintegration analyzers market is estimated to project growth at a robust CAGR of during the forecast period 2022-2032. Significant growth in the pharmaceutical sector and growing demand for more effective oral drugs with faster effects and relief from various ailments and body aches is expected to augment the growth in the global market.
Disintegration analyzers are laboratory equipments commonly used to assess and measure the quality of oral dosage forms such as tablets, pills, and capsules. They evaluate the time and assist in studying how the specific drug in a pallet disintegrates in the solution. Similar to dissolution testing, disintegration is essential pharmacopoeial testing required by the vast majority of solid forms drugs, as it provides critical safety data on drug bioavailability in the human body without performing vivo methods.
The primary function of disintegration analyzers is to analyze and monitor the quality of various drug dosages and their performance by evaluating and calculating the time taken for a pill, tablet, or capsule to disintegrate. In case the results of the test are not as per the pharmacopeia standards, then all the drugs of the specific batch are resent for quality testing. Thus, driven by high importance of disintegration analyzers in the pharmaceutical sector, the market is estimated to register robust growth in the coming years.
Disintegration analyzers are gaining huge popularity across pharmaceutical and biotechnology companies, owing to growing emphasis on enhancing the overall quality of oral drugs and decreasing the time of drug action for faster relief.
Hence, increasing customer inclination towards adoption high quality and fast-relief capsules and tablets for ailments such as headache, acidity, stomach ache, diarrhea, and others are anticipated to propel the demand for disintegration analyzers in the market.
Disintegration analyzers are finding a wide range of applications across pharmaceutical companies for assessing the consistency and uniformity of the production batches. In addition to this, growing emphasis on novel drug development and implementation of stringent drug approval standards by numerous regulatory organizations is augmenting the demand for disintegration analyzers across academic laboratories and research institutes. This is further projected to bolster the growth in the market.
Over the past few years, a substantial rise in burden of conditions such as orthopedic ailments, chronic diseases, and neuropathic pain is being witnessed worldwide, creating strong demand for therapeutic oral capsules, tablets, and pills. For instance, according to a journal published by the America Cancer Society, nearly 19.3 Mn new incidences of cancer were expected to be reported in the year 2020, accounting for around 10 Mn death across the world due to the disease.
This growing prevalence of diseases is augmenting the demand for novel and more effective oral drugs for their therapeutics. As disintegration analyzers play a crucial role in the quality testing processes of oral drugs such as tablets, capsules, pills, growing demand for oral drugs is estimated to create high revenue generation opportunities in the global market.
The safety measures, drug development regulations, and quality standards differ from country to country. Due to this, the product designed and manufactured as per one country's standards may not comply with the regulations and standards of other countries, thereby, restraining the growth in the market.
Also, high cost of disintegration analyzers, need for qualified professionals to operate these equipments, and lack of pharmaceutical lab facilities in certain developing and underdeveloped economies is hinder the sales in the global market.
As per FMI North America is forecast to emerge as the most lucrative market for disintegration analyzers between 2022 and 2032.
Demand for quality testing equipments such as disintegration analyzers is rapidly increasing across the pharmaceutical industry, owing to the growing demand for high-quality oral drugs. Hence, leading manufacturers in the market are increasingly focusing on launching novel quality testing products with innovative technologies and features to capitalize on the existing opportunity.
For instance, Aligent Technologies, an American analytical instruments manufacturer announced introducing new 100 automated disintegration instruments with innovative features such as compact size, swift disconnect fitting, quick conduct sequential testing, and hard copy printout. A slew of such new product launches is estimated to spur the sales in the North America market.
Future Market Insights states that Asia Pacific excluding Japan is anticipated to exhibit rapid growth in the global disintegration analyzers market during the forecast period 2022-2032.
Rising prevalence of chronic ailments and ongoing expansion of the pharmaceutical sector in Asia Pacific has resulted in bolstering the demand for therapeutics oral drugs such as tablets, capsules, and pills across the countries such as India, China, South Korea, and Australia among others.
Hence, key industry players are emphasizing on increasing their production capacity to address this growing demand. For instance, in 2021, Glenmark Life Science, an Indian manufacturer of therapeutics drugs announced its plan to invest around US$ 78.7 Mn for increasing its production capacity to nearly double over the next four years.
As disintegration analyzers are extensively used in pharmaceutical companies for drug quality testing, such developments are projected to spur the sales in the Asia Pacific Excluding Japan market.
Some of the leading players in the disintegration analyzers market are Agilent Technologies, Copley Scientific, Panomex Inc., ERWEKA GmbH, Electrolab, Distek Inc., Veego Instruments Corp., Teledyne Instruments, Yatherm Scientific, and others.
Attributed to increasing research and development activities for launching advanced products by key companies, the market for disintegration analyzers is highly competitive.
| Report Attribute | Details |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Product Type:
By End Use:
By Region:
FMI projects the sales of disintegration analyzers in the market is expected to rise at robust value CAGR by 2032
The global disintegration analyzers market is expected to be dominated by North America the forecast period 2022-2032.
Agilent Technologies, Copley Scientific, Panomex Inc., ERWEKA GmbH, Electrolab, Distek Inc., Veego Instruments Corp., Teledyne Instruments, Yatherm Scientific others are some of the leading players in the prominent disintegration analyzers market.
Explore Similar Insights
Disintegration Analyzers Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
